Web Access Research Portal

Research Output Details

Qiao, L and Zhou, Z and Zeng, X and Tan, C, “Cost-effectiveness of domestic PD-1 inhibitor Camrelizumab combined with chemotherapy in the first-line treatment of advanced nonsquamous non–small-cell lung cancer in China”, Frontiers in Pharmacology, 12 pp. 1-8. ISSN 1663-9812 (2021) [Refereed Article]
Data TypeValue
Type of ResearchApplied Research
Research DivisionEconomics
Research GroupEconometrics
Research FieldEconomic models and forecasting
Research Objective DivisionHealth
Research Objective GroupClinical health
Research Objective FieldTreatment of human diseases and conditions
Visit Item on eCitehttp://ecite.utas.edu.au/147464
Digital Object Identifierdoi:10.3389/fphar.2021.728440
Scopus Source URLView the full record on Scopus
Scopus Citing URLView the list of citing articles on Scopus
Web of Science® Source URLView the full record on Web of Science®
Web of Science® Citing URLView the list of citing articles on Web of Science®
Web of Science® Related URLView the list of related articles on Web of Science®
Number of Times Cited18
Number of Downloads5